Current News
August 4, 2010Maxygen Reports Second Quarter 2010 Financial Results July 16, 2010Maxygen Announces Expiration of Cangene’s Option to License MAXY-G34 for Acute Radiation Syndrome July 6, 2010Perseid Achieves Second Preclinical Milestone under Collaboration with Astellas for CTLA-4 Program May 27, 2010Maxygen Announces $10 Million Stock Repurchase Program March 11, 2010Maxygen Reports Fourth Quarter and Year End 2009 Financial Results January 19, 2010Perseid Achieves Preclinical Milestone under Collaboration with Astellas for CTLA-4 Program
|
